Skip to main content

Closed

AKBA: Akebia Therapeutics, Inc. Company Profile & Overview | finqOS

Healthcare · Biotechnology

52W Range

17thpctl

Volume

0.40×avg

Market Cap

354.10MUSD

P/E Ratio

-17.5TTM

Div Yield

-ann

Akebia Therapeutics, Inc.

AKBANASDAQ Global Market·USD·Closed

Akebia Therapeutics, Inc.

AKBANASDAQ·USD·Closed

$1.32

−2.22%

$1.32

−$0.03 (2.22%)

52W Range

17thpctl

Volume

0.40×avg

Mkt Cap

354.10MUSD

P/E

-17.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings